Bio-Techne achieves milestone of over 10,000 peer-reviewed publications referencing RNAscope technology

Bio-Techne Corporation announced today that Advanced Cell Diagnostics (ACD), part of Bio-Techne’s Spatial Biology Division, has reached a milestone of over 10,000 peer-reviewed publications citing the use and benefits of RNAscope™ ISH technology. More than 50% of these publications have been released in the last 3 years, indicating a growing global recognition and adoption of ACD’s leadership in spatial biology applications.

Being a trailblazer in spatial biology, Bio-Techne offers a comprehensive range of over 50,000 unique RNAscope™ ISH probes for over 400 species. This enables biopharma and academic researchers to make groundbreaking discoveries, expedite the development of advanced therapies, and provide innovative diagnostics. RNAscope™ is renowned for its exceptional single-molecule sensitivity and precise subcellular resolution, making it the most referenced spatial biology technology for RNA biomarkers in the industry. The 10,000 scientific publications span various fields such as cancer, neuroscience, immunology, infectious diseases, cell and gene therapy, and regenerative medicine.

Matt McManus, the President of Bio-Techne’s Diagnostics & Genomics Segment, expressed excitement about the milestone achievement of 10,000 publications referencing RNAscope™ ISH technology. He conveyed gratitude for the confidence shown by the scientific community in utilizing RNAscope™ to uncover new spatial insights and facilitate significant advancements in diverse disease areas.

By Samantha Robertson

As a seasoned content writer at, my passion for storytelling and creativity shines through in every article I craft. With a keen eye for detail and a knack for research, I thrive on translating complex topics into engaging reads that resonate with our diverse audience. My goal is to inform, entertain, and inspire readers through thought-provoking content that leaves a lasting impact. Join me on this exciting journey as we explore the world of news together.

Leave a Reply